2022-502277-41-00已完成1 期
A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Camizestrant in Post-menopausal Female Subjects
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 14
- 试验地点
- 3
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
AstraZeneca Information Center
Scientific
AstraZeneca AB
研究点 (3)
Loading locations...
相似试验
招募中
1 期
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Liver FunctionNCT07269301Pfizer26
已完成
不适用
HAIC vs. TACE Combined With ICIs and TKIs in Intermediate-to-Advanced HCC: A Multicenter Study on Liver Injury and SurvivalLiver InjuryNCT07277192Nanfang Hospital, Southern Medical University562
进行中（未招募）
不适用
Pharmacokinetics study on Thiotepa in children scheduled for allogenic bone marrow transplantatioPatients with various hematological disease requiring Bone Marrow Transplantation, with Child-Pugh score A and BMedDRA version: 17.0Level: LLTClassification code 10067859Term: Allogenic stem cell transplantationSystem Organ Class: 100000004865EUCTR2014-004371-22-ITADIENNE SA
尚未招募
不适用
Role of Omega-6 Fatty Acids in Hepatocellular Carcinoma Development.NCT07265076Sohag University100
Enrolling By Invitation
1 期
Safety, Tolerability, and Preliminary Efficacy of Hepatocyte-like Cell Injection for the Prevention and Treatment of Small-for-Size SyndromeSmall-for-size SyndromeAcute Liver FailureChronic Liver FailureNCT07276568Zhi-Jun Zhu12